Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laruelle

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Schizophrenia Bulletin|September 17, 2005
Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophreniaRaymond Y Cho, Judith M Ford, John H Krystal, et al.
Psychopharmacology|March 17, 2004
In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primatesMark Slifstein, Dah-Ren Hwang, Yiyun Huang, et al.
Nuclear Medicine and Biology|May 28, 2003
Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptorsFilip Dumont, Rikki N Waterhouse, Julie A Montoya, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 22, 2007
[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjectsMark Slifstein, Lawrence S Kegeles, Robyn Gonzales, et al.
Neuroimage|July 26, 2011
Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tonePeter S Talbot, Mark Slifstein, Dah-Ren Hwang, et al.
Nuclear Medicine and Biology|June 29, 2004
A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM)Yiyun Huang, Dah-Ren Hwang, Sung-A Bae, et al.
Depression and Anxiety|January 31, 2009
Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorderFranklin R Schneier, Anissa Abi-Dargham, Diana Martinez, et al.
Nuclear Medicine and Biology|July 13, 2004
A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA)Yiyun Huang, Raj Narendran, Sung-A Bae, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PETMark Slifstein, Dah-Ren Hwang, Diana Martinez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2007
D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophreniaDavid Mamo, Shitij Kapur, Matcheri Keshavan, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Schizophrenia Bulletin|September 17, 2005
Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophreniaRaymond Y Cho, Judith M Ford, John H Krystal, et al.
Psychopharmacology|March 17, 2004
In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primatesMark Slifstein, Dah-Ren Hwang, Yiyun Huang, et al.
Nuclear Medicine and Biology|May 28, 2003
Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptorsFilip Dumont, Rikki N Waterhouse, Julie A Montoya, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 22, 2007
[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjectsMark Slifstein, Lawrence S Kegeles, Robyn Gonzales, et al.
Neuroimage|July 26, 2011
Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tonePeter S Talbot, Mark Slifstein, Dah-Ren Hwang, et al.
Nuclear Medicine and Biology|June 29, 2004
A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM)Yiyun Huang, Dah-Ren Hwang, Sung-A Bae, et al.
Depression and Anxiety|January 31, 2009
Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorderFranklin R Schneier, Anissa Abi-Dargham, Diana Martinez, et al.
Nuclear Medicine and Biology|July 13, 2004
A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA)Yiyun Huang, Raj Narendran, Sung-A Bae, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PETMark Slifstein, Dah-Ren Hwang, Diana Martinez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2007
D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophreniaDavid Mamo, Shitij Kapur, Matcheri Keshavan, et al.
Pageof 11